Does ischaemia-modified albumin level predict clomiphene citrate resistant polycystic ovary syndrome patients?
Adult
Biomarkers
/ blood
Clomiphene
/ therapeutic use
Drug Resistance
/ physiology
Female
Fertility Agents, Female
/ therapeutic use
Humans
Infertility, Female
/ drug therapy
Oxidative Stress
/ physiology
Polycystic Ovary Syndrome
/ blood
Predictive Value of Tests
Primary Ovarian Insufficiency
/ drug therapy
Prospective Studies
Reactive Oxygen Species
/ metabolism
Serum Albumin, Human
Young Adult
Ischaemia-modified albumin
clomiphene citrate resistance
oxidative stress
polycystic ovary syndrome
Journal
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
ISSN: 1364-6893
Titre abrégé: J Obstet Gynaecol
Pays: England
ID NLM: 8309140
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
18
8
2020
medline:
25
2
2023
entrez:
18
8
2020
Statut:
ppublish
Résumé
This study aims to examine the role of ischaemic-modified albumin (IMA) in predicting clomiphene citrate (CC) resistance in patients with CC-resistant and CC-sensitive infertile polycystic ovary syndrome (PCOS). Sixty women patients admitted to the infertility clinic were evaluated. The patients were divided into two groups. Group 1 comprised 30 infertile PCOS patients with CC resistance; group 2 was the control group comprising 30 infertile PCOS patients with CC sensitivity. Serum IMA levels of PCOS patients with CC resistance were significantly higher than CC sensitivity patients (
Identifiants
pubmed: 32799715
doi: 10.1080/01443615.2020.1785407
doi:
Substances chimiques
Biomarkers
0
Fertility Agents, Female
0
Reactive Oxygen Species
0
ischemia-modified albumin
0
Clomiphene
1HRS458QU2
Serum Albumin, Human
ZIF514RVZR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM